The probes & catheters segment by device is estimated to lead the market growth during the forecast period.
According to this study, the North America non-invasive cardiac output monitoring device market is expected to reach US$ 1,29,912.44 thousand by 2027 from US$ 87,713.76 thousand in 2019; it is estimated to grow at a CAGR of 5.1% from 2020 to 2027. The report highlights trends prevailing in the North America non-invasive cardiac output monitoring device market and the factors driving market along with those that act as hindrances.
Based on device, the North America non-invasive cardiac output monitoring device market is segmented into patches, wristwatches, and probes & catheters. The probes & catheters segment held the largest share of the market in 2019. However, wristwatches segment is estimated to register the highest CAGR in the market during the forecast period. In recent years, many minimally invasive or non-invasive devices have been developed to measure cardiac output (CO), which is essential in a medical practice. Cardiac output gives information about tissue perfusion and oxygen delivery as well as can identify patients who are at high risk of mortality or morbidity. According to the estimates of the Centers for Disease Control and Prevention (CDC), one person dies every 36 seconds due to cardiovascular diseases (CVD) in the US. Thus, the growing prevalence of CVD is boosting the adoption of non-invasive cardiac output monitoring devices. Similarly, geriatric populations are susceptible to many chronic diseases. Most of them suffer from multiple diseases such as diabetes, heart diseases, and pulmonary diseases and some of them undergo surgeries. Non-invasive cardiac output (CO) monitoring is one of the important modern medical practices used while observing critically ill patients. As per the data from World Population Prospects: the 2019 Revision, one in four people in North America would be aged 65 or more by 2050. Moreover, the number of people aged 80 years and above is projected to increase by three-folds from 143 million in 2019 to 426 million by 2050. Thus, increasing geriatric population favours the growth of the market.
North America is highly affected due to the outbreak of the COVID-19. The chaotic situation is observed in the medical industry across the countries, as there is increased demand for COVID-19 diagnostics and therapeutics in the hospitals. Hence, as various hospitals and healthcare organizations are struggling with the outbreak crisis, companies are focusing on the production of diagnostic kits and monitoring systems. In addition, the COVID-19 pandemic is perplexing healthcare institutions in the region with unprecedented operational and clinical challenges. Moreover, the shift of priorities from cardiovascular treatment to COVID-19 diagnosis is reducing the use of non-invasive cardiac output monitoring device, leading to decline in the growth of the North America non-invasive cardiac output monitoring device up to certain extent.
A few of the major primary and secondary sources referred to while preparing the report on the North America non-invasive cardiac output monitoring device market are the U.S Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and American Heart Association (AHA).
General Electric Company, Koninklijke Philips N.V., Abbott, DELTEX MEDICAL, LiDCO, CONMED Corporation, ImaCor, NIMedical and Baxter International Inc. are among the leading companies operating in the North America non-invasive cardiac output monitoring device market.
The report segments in North America Non-Invasive Cardiac Output Monitoring Device Market as follows:
By Device
By Indication
By End User
By Country
Based on device, the North America non-invasive cardiac output monitoring device market is segmented into patches, wristwatches, and probes & catheters. The probes & catheters segment held the largest share of the market in 2019. However, wristwatches segment is estimated to register the highest CAGR in the market during the forecast period. In recent years, many minimally invasive or non-invasive devices have been developed to measure cardiac output (CO), which is essential in a medical practice. Cardiac output gives information about tissue perfusion and oxygen delivery as well as can identify patients who are at high risk of mortality or morbidity. According to the estimates of the Centers for Disease Control and Prevention (CDC), one person dies every 36 seconds due to cardiovascular diseases (CVD) in the US. Thus, the growing prevalence of CVD is boosting the adoption of non-invasive cardiac output monitoring devices. Similarly, geriatric populations are susceptible to many chronic diseases. Most of them suffer from multiple diseases such as diabetes, heart diseases, and pulmonary diseases and some of them undergo surgeries. Non-invasive cardiac output (CO) monitoring is one of the important modern medical practices used while observing critically ill patients. As per the data from World Population Prospects: the 2019 Revision, one in four people in North America would be aged 65 or more by 2050. Moreover, the number of people aged 80 years and above is projected to increase by three-folds from 143 million in 2019 to 426 million by 2050. Thus, increasing geriatric population favours the growth of the market.
North America is highly affected due to the outbreak of the COVID-19. The chaotic situation is observed in the medical industry across the countries, as there is increased demand for COVID-19 diagnostics and therapeutics in the hospitals. Hence, as various hospitals and healthcare organizations are struggling with the outbreak crisis, companies are focusing on the production of diagnostic kits and monitoring systems. In addition, the COVID-19 pandemic is perplexing healthcare institutions in the region with unprecedented operational and clinical challenges. Moreover, the shift of priorities from cardiovascular treatment to COVID-19 diagnosis is reducing the use of non-invasive cardiac output monitoring device, leading to decline in the growth of the North America non-invasive cardiac output monitoring device up to certain extent.
A few of the major primary and secondary sources referred to while preparing the report on the North America non-invasive cardiac output monitoring device market are the U.S Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and American Heart Association (AHA).
General Electric Company, Koninklijke Philips N.V., Abbott, DELTEX MEDICAL, LiDCO, CONMED Corporation, ImaCor, NIMedical and Baxter International Inc. are among the leading companies operating in the North America non-invasive cardiac output monitoring device market.
The report segments in North America Non-Invasive Cardiac Output Monitoring Device Market as follows:
By Device
- Patches
- Wristwatches
- Probes & Catheters
By Indication
- Hypertension
- Coronary Diseases
- Congenital Problems
- Myocardial Ischemia and Infarction
- Heart Failure
- Arrhythmias
- Others
By End User
- Hospitals
- Emergency Services Centers
- Homecare
- Others
By Country
- US
- Canada
- Mexico
Table of Contents
1. Introduction
3. Research Methodology
4. South and Central America Non-Invasive Cardiac Output Monitoring Device - Market Landscape
5. Non-Invasive Cardiac Output Monitoring Device Market - Key Market Dynamics
6. Non-Invasive Cardiac Output Monitoring Device Market - North America Analysis
7. Non-invasive Cardiac Output Monitoring Device Market- By Device
8. Non-Invasive Cardiac Output Monitoring Device Market- By Indication
9. Non-Invasive Cardiac Output Monitoring Device Market- By End User
10. Non-invasive Cardiac Output Monitoring Device Market - North America Analysis
11. Impact Of COVID-19 Pandemic on North America Non-invasive Cardiac Output Monitoring Device Market
12. Non-invasive Cardiac Output Monitoring Device Market- Industry Landscape
13. Company Profiles
14. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- General Electric Company
- Koninklijke Philips N.V.
- Abbott
- DELTEX MEDICAL
- LiDCO
- CONMED Corporation
- ImaCor
- NIMedical
- Baxter International Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 123 |
| Published | June 2021 |
| Forecast Period | 2020 - 2027 |
| Estimated Market Value ( USD | $ 95471.09 Million |
| Forecasted Market Value ( USD | $ 129912.44 Million |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | North America |
